![Jörgen Dahlström](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jörgen Dahlström currently works at Mercodia AB, as Chief Executive Officer from 2021 and Prostatype Genomics AB, as Independent Director from 2023.
Dr. Dahlström received his graduate degree and doctorate degree from the University of Uppsala.
| Companies | Position | Start |
|---|---|---|
| PROSTATYPE GENOMICS AB | Director/Board Member | 2022-12-31 |
Mercodia AB
 Mercodia AB Medical SpecialtiesHealth Technology Develops, manufactures and distributes immunoassay kits | Chief Executive Officer | 2021-09-30 |
Active
Inactive
Listed companies
Private companies
| Private companies | 3 |
|---|---|
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mercodia AB
Mercodia AB Medical SpecialtiesHealth Technology Develops, manufactures and distributes immunoassay kits | Health Technology |
Prostatype Genomics AB
 Prostatype Genomics AB Medical SpecialtiesHealth Technology Develops, manufactures and markets prognostic genetic test prostatype equipment | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
